Evidence map›Paper›PMID 16648477›Full record

ArticleMolecular and cellular biology2006

Determinants that control the specific interactions between TAB1 and p38alpha.

Huamin Zhou, Min Zheng, Jianming Chen, Changchuan Xie, Anand R Kolatkar, Tyler Zarubin, Zhiyun Ye, Radha Akella, Shengcai Lin, Elizabeth J Goldsmith and 1 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in Molecular and cellular biology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Atypical p38 Signaling, Activation, and Implications for Disease.International journal of molecular sciences · 2021
    Review
  3. The p38 Pathway: From Biology to Cancer Therapy.International journal of molecular sciences · 2020
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Disruption of TAB1/p38α interaction using a cell-permeable peptide limits myocardial ischemia/reperfusion injury.Molecular therapy : the journal of the American Society of Gene Therapy · 2013
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway.Proceedings of the National Academy of Sciences of the United States of America · 2010
    Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Huamin ZhouThe Key Laboratory of the Ministry of Education for Cell Biology and Tumor Cell Engineering, School of Life Sciences, Xiamen University, Fujian, China.
Min Zheng
Jianming Chen
Changchuan Xie
Anand R Kolatkar
Tyler Zarubin
Zhiyun Ye
Radha Akella
Shengcai Lin
Elizabeth J Goldsmith
Jiahuai Han
Scripps Research Institute · USXiamen University · CNThe University of Texas Southwestern Medical Center · US

Funding

TLR activation of Rho GTPase regulated signaling pathwayP01GM037696 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI TEYTON, LUC · 1987 to 2006
$9.0M
CELLULAR ACTIVATION MECHANISMS IN SEPTIC SHOCKR01AI041637 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI TOBIAS, PETER S · 1997 to 2012
$4.6M
SPECIFICITY AND DIMERIZATION IN MAP KINASE INTERACTIONSR01DK046993 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI GOLDSMITH, ELIZABETH J. · 1994 to 2010
$3.0M
NIAID NIH HHS AI41637NIAID NIH HHS R01 AI041637NIDDK NIH HHS DK46993NIDDK NIH HHS R01 DK046993NIGMS NIH HHS GM37696NIGMS NIH HHS P01 GM037696
6 · The paper itself

Abstract

Previous studies have revealed that transforming growth factor-beta-activated protein kinase 1 (TAB1) interacts with p38alpha and induces p38alpha autophosphorylation. Here, we examine the sequence requirements in TAB1 and p38alpha that drive their interaction. Deletion and point mutations in TAB1 reveal that a proline residue in the C terminus of TAB1 (Pro412) is necessary for its interaction with p38alpha. Furthermore, a cryptic D-domain-like docking site was identified adjacent to the N terminus of Pro412, putting Pro412 in the phi(B)+3 position of the docking site. Through mutational analysis, we found that the previously identified hydrophobic docking groove in p38alpha is involved in this interaction, whereas the CD domain and ED domain are not. Furthermore, chimeric analysis with p38beta (which does not bind to TAB1) revealed a previously unidentified locus of p38alpha comprising Thr218 and Ile275 that is essential for specific binding of p38alpha to TAB1. Converting either of these residues to the corresponding amino acid of p38beta abolishes p38alpha interaction with TAB1. These p38alpha mutants still can be fully activated by p38alpha upstream activating kinase mitogen-activated protein kinase kinase 6, but their basal activity and activation in response to some extracellular stimuli are reduced. Adjacent to Thr218 and Ile275 is a site where large conformational changes occur in the presence of docking-site peptides derived from p38alpha substrates and activators. This suggests that TAB1-induced autophosphorylation of p38alpha results from conformational changes that are similar but unique to those seen in p38alpha interactions with its substrates and activating kinases.

Indexed as

Adaptor Proteins, Signal TransducingAlanineAmino Acid MotifsAmino Acid SequenceAmino Acid Substitutionbeta-GalactosidaseBinding SitesBlotting, WesternCell Culture TechniquesCell LineCircular DichroismDNA Mutational AnalysisEnzyme ActivationEscherichia coliGene DeletionGenes, ReporterAdaptor Proteins, Signal TransducingAlaninebeta-GalactosidaseLuciferasesMitogen-Activated Protein Kinase 14Recombinant Fusion ProteinsTAB1 protein, humanThreonine

Identifiers

PMID16648477
PMCPMC1489000
OpenAlexW2102956977

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.